<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Google, Genentech fund personal-genetics startup 23andMe</title>
	<atom:link href="http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Tue, 24 Nov 2009 05:47:06 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: VentureBeat &#187; 23andMe&#8217;s European vacation and other personal-genomics notes</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-759768</link>
		<dc:creator>VentureBeat &#187; 23andMe&#8217;s European vacation and other personal-genomics notes</dc:creator>
		<pubDate>Tue, 29 Jan 2008 19:51:38 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-759768</guid>
		<description>[...] to capitalize on the company&#8217;s close association with Google&#8217;s star power (Google is a 23andMe investor). And, to her credit, Wojcicki appears to be downplaying the usefulness of disease-risk prediction [...]</description>
		<content:encoded><![CDATA[<p>[...] to capitalize on the company&#8217;s close association with Google&#8217;s star power (Google is a 23andMe investor). And, to her credit, Wojcicki appears to be downplaying the usefulness of disease-risk prediction [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; deCODEme and its questionable disease-risk predictions</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-754294</link>
		<dc:creator>VentureBeat &#187; deCODEme and its questionable disease-risk predictions</dc:creator>
		<pubDate>Sat, 26 Jan 2008 21:38:15 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-754294</guid>
		<description>[...] to capitalize on the company&#8217;s close association with Google&#8217;s star power (Google is a 23andMe investor). And, to her credit, Wojcicki appears to be downplaying the usefulness of disease-risk prediction [...]</description>
		<content:encoded><![CDATA[<p>[...] to capitalize on the company&#8217;s close association with Google&#8217;s star power (Google is a 23andMe investor). And, to her credit, Wojcicki appears to be downplaying the usefulness of disease-risk prediction [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Sarah</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-644212</link>
		<dc:creator>Sarah</dc:creator>
		<pubDate>Wed, 21 Nov 2007 06:33:30 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-644212</guid>
		<description>It costs $1000 per person to get tested.  This sounds like something that would best serve the affluent.  To most people $1000 means a mortgage payment.  However, there are plenty of other DNA testing companies running so there must be a market for it.  My question is say you find out that cancer runs in your family, what is the next step?  It is not as though you can prevent something from happening simply by knowing about it.  23andme may want to branch out and provide other more affordable tests to the general public, rather than limit their service to only a $1000 kit.</description>
		<content:encoded><![CDATA[<p>It costs $1000 per person to get tested.  This sounds like something that would best serve the affluent.  To most people $1000 means a mortgage payment.  However, there are plenty of other DNA testing companies running so there must be a market for it.  My question is say you find out that cancer runs in your family, what is the next step?  It is not as though you can prevent something from happening simply by knowing about it.  23andme may want to branch out and provide other more affordable tests to the general public, rather than limit their service to only a $1000 kit.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; 23andMe lets you search and share your genome &#8212; today</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-639620</link>
		<dc:creator>VentureBeat &#187; 23andMe lets you search and share your genome &#8212; today</dc:creator>
		<pubDate>Sat, 17 Nov 2007 19:27:25 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-639620</guid>
		<description>[...] Google, Genentech fund personal-genetics startup 23andMe [...]</description>
		<content:encoded><![CDATA[<p>[...] Google, Genentech fund personal-genetics startup 23andMe [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Will 23andMe and Navigenics lock up your genome and hold onto the key?</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-593798</link>
		<dc:creator>VentureBeat &#187; Will 23andMe and Navigenics lock up your genome and hold onto the key?</dc:creator>
		<pubDate>Wed, 24 Oct 2007 16:18:01 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-593798</guid>
		<description>[...] Google, Genentech fund personal-genetics startup 23andMe [...]</description>
		<content:encoded><![CDATA[<p>[...] Google, Genentech fund personal-genetics startup 23andMe [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Thursday, Oct. 4, 2007</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-562802</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Thursday, Oct. 4, 2007</dc:creator>
		<pubDate>Thu, 04 Oct 2007 16:39:17 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-562802</guid>
		<description>[...] however, this isn&#8217;t new funding. When the personal-genomics startup (see our coverage here and here) announced its funding back in May, all we knew was that Google had invested $3.9 million, [...]</description>
		<content:encoded><![CDATA[<p>[...] however, this isn&#8217;t new funding. When the personal-genomics startup (see our coverage here and here) announced its funding back in May, all we knew was that Google had invested $3.9 million, [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Complete Genomics and BioNanomatrix rev up the fast, cheap and out-of-control genome race</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-559204</link>
		<dc:creator>VentureBeat &#187; Complete Genomics and BioNanomatrix rev up the fast, cheap and out-of-control genome race</dc:creator>
		<pubDate>Mon, 01 Oct 2007 18:15:17 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-559204</guid>
		<description>[...] startups like 23andMe and Navigenics would like to provide &#8212; our coverage is here, here and here.) This is a potentially huge problem for companies like DNA Direct, one of the first [...]</description>
		<content:encoded><![CDATA[<p>[...] startups like 23andMe and Navigenics would like to provide &#8212; our coverage is here, here and here.) This is a potentially huge problem for companies like DNA Direct, one of the first [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; The decoding of 23andMe proceeds apace</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-531400</link>
		<dc:creator>VentureBeat &#187; The decoding of 23andMe proceeds apace</dc:creator>
		<pubDate>Thu, 13 Sep 2007 14:53:32 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-531400</guid>
		<description>[...] Brin&#8217;s new wife, Anne Wojcicki, and now backed by Google and Genentech. (See our coverage here.) Now more details about the company&#8217;s plans to help individuals map their own genomes are [...]</description>
		<content:encoded><![CDATA[<p>[...] Brin&#8217;s new wife, Anne Wojcicki, and now backed by Google and Genentech. (See our coverage here.) Now more details about the company&#8217;s plans to help individuals map their own genomes are [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; The decoding of 23andMe proceeds apace</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-531414</link>
		<dc:creator>VentureBeat &#187; The decoding of 23andMe proceeds apace</dc:creator>
		<pubDate>Thu, 13 Sep 2007 14:53:32 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-531414</guid>
		<description>[...] Brin&#8217;s new wife, Anne Wojcicki, and now backed by Google and Genentech. (See our coverage here.) Now more details about the company&#8217;s plans to help individuals map their own genomes are [...]</description>
		<content:encoded><![CDATA[<p>[...] Brin&#8217;s new wife, Anne Wojcicki, and now backed by Google and Genentech. (See our coverage here.) Now more details about the company&#8217;s plans to help individuals map their own genomes are [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Personal-genetics startup Navigenics, a potential 23andMe competitor, unstealths</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-483366</link>
		<dc:creator>VentureBeat &#187; Personal-genetics startup Navigenics, a potential 23andMe competitor, unstealths</dc:creator>
		<pubDate>Sun, 19 Aug 2007 20:57:59 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-483366</guid>
		<description>[...] is very similar to what 23andMe, a similar startup backed by Google and Genentech (see our coverage here and here), intends to do. Adding to the intrigue is the fact that Navigenics has some influential [...]</description>
		<content:encoded><![CDATA[<p>[...] is very similar to what 23andMe, a similar startup backed by Google and Genentech (see our coverage here and here), intends to do. Adding to the intrigue is the fact that Navigenics has some influential [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Quebec's Genetic Map - CARTaGENE &#8212; Eye on DNA</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-178782</link>
		<dc:creator>Quebec's Genetic Map - CARTaGENE &#8212; Eye on DNA</dc:creator>
		<pubDate>Wed, 23 May 2007 10:49:45 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-178782</guid>
		<description>[...] I commented today over at VentureBeat Life Sciences with respect to 23andMe, one of the main concerns for participants has got to be about privacy and [...]</description>
		<content:encoded><![CDATA[<p>[...] I commented today over at VentureBeat Life Sciences with respect to 23andMe, one of the main concerns for participants has got to be about privacy and [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Hsien Lei</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-178376</link>
		<dc:creator>Hsien Lei</dc:creator>
		<pubDate>Wed, 23 May 2007 08:32:48 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-178376</guid>
		<description>Great coverage, David. 23andMe has done a great job keeping a lid on the specifics of what they&#039;re doing. You can almost imagine that they&#039;re hoping to do touch on every DNA technology that&#039;s possible up to now and somehow make it relevant to the consumer. I think their success will hinge on 2 things:

1) Do people understand genetics to the extent that they&#039;d be willing to pay money to play with their own DNA sequence? Are there enough of these types of people to make a profitable business? (And the cost of sequencing is another question. Most DNA tests cost in the range of $300-400. Got any cash under the sofa cushion?)

2) From my observations, privacy and the fear of Gattaca is first on people&#039;s minds when they consider the potential of having their DNA sequenced. I must admit that even though I&#039;ve been involved in genetics almost all my life (from elementary school on...), I haven&#039;t come close to having my DNA tested in any way shape or form.</description>
		<content:encoded><![CDATA[<p>Great coverage, David. 23andMe has done a great job keeping a lid on the specifics of what they&#8217;re doing. You can almost imagine that they&#8217;re hoping to do touch on every DNA technology that&#8217;s possible up to now and somehow make it relevant to the consumer. I think their success will hinge on 2 things:</p>
<p>1) Do people understand genetics to the extent that they&#8217;d be willing to pay money to play with their own DNA sequence? Are there enough of these types of people to make a profitable business? (And the cost of sequencing is another question. Most DNA tests cost in the range of $300-400. Got any cash under the sofa cushion?)</p>
<p>2) From my observations, privacy and the fear of Gattaca is first on people&#8217;s minds when they consider the potential of having their DNA sequenced. I must admit that even though I&#8217;ve been involved in genetics almost all my life (from elementary school on&#8230;), I haven&#8217;t come close to having my DNA tested in any way shape or form.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Personal Genome Company 23andMe Receives Google Investment &#8212; Eye on DNA</title>
		<link>http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/comment-page-1/#comment-178362</link>
		<dc:creator>Personal Genome Company 23andMe Receives Google Investment &#8212; Eye on DNA</dc:creator>
		<pubDate>Wed, 23 May 2007 08:32:12 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/22/google-genentech-fund-personal-genetics-startup-23andme/#comment-178362</guid>
		<description>[...] Google, Genentech fund personal-genetics startup 23andMe [...]</description>
		<content:encoded><![CDATA[<p>[...] Google, Genentech fund personal-genetics startup 23andMe [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
